Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

MLA

Robach, Paul, et al. “Alterations of Systemic and Muscle Iron Metabolism in Human Subjects Treated with Low-Dose Recombinant Erythropoietin.” Blood, vol. 113, no. 26, June 2009, pp. 6707–15. EBSCOhost, https://doi.org/10.1182/blood-2008-09-178095.

APA

Robach, P., Recalcati, S., Girelli, D., Gelfi, C., Aachmann-Andersen, N. J., Thomsen, J. J., Norgaard, A. M., Alberghini, A., Campostrini, N., Castagna, A., Viganò, A., Santambrogio, P., Kempf, T., Wollert, K. C., Moutereau, S., Lundby, C., & Cairo, G. (2009). Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin. Blood, 113(26), 6707–6715. https://doi.org/10.1182/blood-2008-09-178095

Chicago

Robach, Paul, Stefania Recalcati, Domenico Girelli, Cecilia Gelfi, Niels J Aachmann-Andersen, Jonas J Thomsen, Anne M Norgaard, et al. 2009. “Alterations of Systemic and Muscle Iron Metabolism in Human Subjects Treated with Low-Dose Recombinant Erythropoietin.” Blood 113 (26): 6707–15. doi:10.1182/blood-2008-09-178095.